Healthcare -
Biotechnology - NASDAQ - US
$ 2.6
4 %
$ 358 M
Market Cap
-7.43
P/E
Price Target
Average
92.31%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.99%
Net Income
Estimate
63.16%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Compass Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for CMPX of $5 , with forecasts ranging from
a
low of
$5 to a high of $5 .
CMPX Lowest Price Target
Wall Street Target
5 USD
92.31%
CMPX Average Price Target
Wall Street Target
5 USD
92.31%
CMPX Highest Price Target
Wall Street Target
5 USD
92.31%
REVENUE FORECAST
Revenue Forecast Chart CMPX
EBIT FORECAST
EBIT Forecast Chart CMPX
NET INCOME FORECAST
Net Income Chart CMPX